Company Filing History:
5 out of 5 
2 out of 17 
2 out of 3 Years Active: 2014-2025
Title: The Innovative Contributions of Dubravka Drabek
Introduction
Dubravka Drabek is a prominent inventor based in Rotterdam, Netherlands. She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of nine patents to her name, Drabek's work has the potential to impact the treatment of various diseases, including cancers and autoimmune disorders.
Latest Patents
Among her latest patents is the invention of antibodies binding to CTLA-4. These isolated monoclonal antibodies comprise a CD152-binding domain, specifically targeting human CD152. The methods of making and using these antibodies are designed to treat diseases, including cancers and autoimmune diseases. This innovative approach showcases her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Drabek has had a distinguished career, working at esteemed institutions such as Erasmus University Medical Centre. Her research and inventions have garnered attention in the scientific community, highlighting her expertise and dedication to her field.
Collaborations
Throughout her career, Drabek has collaborated with notable colleagues, including Roger Kingdon Craig and Franklin Gerardus Grosveld. These partnerships have further enriched her research and contributed to her success as an inventor.
Conclusion
Dubravka Drabek's innovative work in the field of biotechnology, particularly her patents related to monoclonal antibodies, underscores her significant contributions to medical science. Her dedication to advancing treatment options for serious diseases is commendable and reflects her status as a leading inventor in her field.